Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adrenergic signaling in cardiomyocytes 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D00511 💬 Phenylephrine 1件: 22 💬
2 Adrenergic signaling in cardiomyocytes 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D08365 💬 Phenylephrine 1件: 22 💬
3 Adrenergic signaling in cardiomyocytes 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D00076 💬 Norepinephrine 1件: 22 💬
4 Adrenergic signaling in cardiomyocytes 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D05206 💬 Norepinephrine 1件: 22 💬
5 Alzheimer disease 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
6 AMPK signaling pathway 💬
1件: ADRA1A 💬 D00076 💬 Norepinephrine 1件: 22 💬
7 AMPK signaling pathway 💬
1件: ADRA1A 💬 D05206 💬 Norepinephrine 1件: 22 💬
8 AMPK signaling pathway 💬
1件: ADRA1A 💬 D00511 💬 Phenylephrine 1件: 22 💬
9 AMPK signaling pathway 💬
1件: ADRA1A 💬 D08365 💬 Phenylephrine 1件: 22 💬
10 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
11 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
12 Calcium signaling pathway 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D00511 💬 Phenylephrine 1件: 22 💬
13 Calcium signaling pathway 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D08365 💬 Phenylephrine 1件: 22 💬
14 Calcium signaling pathway 💬
6件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 💬 D00076 💬 Norepinephrine 1件: 22 💬
15 Calcium signaling pathway 💬
6件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 💬 D05206 💬 Norepinephrine 1件: 22 💬
16 cAMP signaling pathway 💬
2件: ADRB1, ADRB2 💬 D00076 💬 Norepinephrine 1件: 22 💬
17 cAMP signaling pathway 💬
2件: ADRB1, ADRB2 💬 D05206 💬 Norepinephrine 1件: 22 💬
18 cGMP-PKG signaling pathway 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D00511 💬 Phenylephrine 1件: 22 💬
19 cGMP-PKG signaling pathway 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D08365 💬 Phenylephrine 1件: 22 💬
20 cGMP-PKG signaling pathway 💬
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 D00076 💬 Norepinephrine 1件: 22 💬
21 cGMP-PKG signaling pathway 💬
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 D05206 💬 Norepinephrine 1件: 22 💬
22 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
23 Chemical carcinogenesis - receptor activation 💬
3件: ADRB1, ADRB2, ADRB3 💬 D00076 💬 Norepinephrine 1件: 22 💬
24 Chemical carcinogenesis - receptor activation 💬
3件: ADRB1, ADRB2, ADRB3 💬 D05206 💬 Norepinephrine 1件: 22 💬
25 Cytokine-cytokine receptor interaction 💬
1件: EPOR 💬 D03231 💬 Erythropoietin 10件:  2 ,  6 , 13, 18, 22, 46, 47, 70, 95, 96 💬
26 Dilated cardiomyopathy 💬
1件: ADRB1 💬 D00076 💬 Norepinephrine 1件: 22 💬
27 Dilated cardiomyopathy 💬
1件: ADRB1 💬 D05206 💬 Norepinephrine 1件: 22 💬
28 GABAergic synapse 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 10件:  6 , 21, 22, 34, 46, 70, 75, 84, 98, 296 💬
29 Gap junction 💬
1件: ADRB1 💬 D00076 💬 Norepinephrine 1件: 22 💬
30 Gap junction 💬
1件: ADRB1 💬 D05206 💬 Norepinephrine 1件: 22 💬
31 Hematopoietic cell lineage 💬
1件: EPOR 💬 D03231 💬 Erythropoietin 10件:  2 ,  6 , 13, 18, 22, 46, 47, 70, 95, 96 💬
32 Human cytomegalovirus infection 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
33 Human papillomavirus infection 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
34 IL-17 signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
35 JAK-STAT signaling pathway 💬
1件: EPOR 💬 D03231 💬 Erythropoietin 10件:  2 ,  6 , 13, 18, 22, 46, 47, 70, 95, 96 💬
36 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
37 Leishmaniasis 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
38 Metabolic pathways 💬
2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
39 MicroRNAs in cancer 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
40 Morphine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 10件:  6 , 21, 22, 34, 46, 70, 75, 84, 98, 296 💬
41 Neuroactive ligand-receptor interaction 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D00511 💬 Phenylephrine 1件: 22 💬
42 Neuroactive ligand-receptor interaction 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D08365 💬 Phenylephrine 1件: 22 💬
43 Neuroactive ligand-receptor interaction 💬
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 D00076 💬 Norepinephrine 1件: 22 💬
44 Neuroactive ligand-receptor interaction 💬
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 D05206 💬 Norepinephrine 1件: 22 💬
45 Neuroactive ligand-receptor interaction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 10件:  6 , 21, 22, 34, 46, 70, 75, 84, 98, 296 💬
46 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
47 Nicotine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 10件:  6 , 21, 22, 34, 46, 70, 75, 84, 98, 296 💬
48 Ovarian steroidogenesis 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
49 Oxytocin signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
50 Pathways in cancer 💬
1件: EPOR 💬 D03231 💬 Erythropoietin 10件:  2 ,  6 , 13, 18, 22, 46, 47, 70, 95, 96 💬
51 Pathways in cancer 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
52 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
53 PI3K-Akt signaling pathway 💬
1件: EPOR 💬 D03231 💬 Erythropoietin 10件:  2 ,  6 , 13, 18, 22, 46, 47, 70, 95, 96 💬
54 Platelet activation 💬
1件: PTGS1 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
55 Regulation of lipolysis in adipocytes 💬
3件: ADRB1, ADRB2, ADRB3 💬 D00076 💬 Norepinephrine 1件: 22 💬
56